CS logo
small CS logo
Hospital Nacional Cayetano Heredia

Lima, Peru
Hospital in San Martín de Porres District
1 CV Zac, Av. Honorio Delgado 262, San Martín de Porres 15102

About Hospital Nacional Cayetano Heredia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Universidad Peruana Cayetano Heredia
13
Hoffmann-La Roche
6
Bristol-Myers Squibb
4
Genentech, Inc.
2
Mallinckrodt
2
Apellis Pharmaceuticals, Inc.
1
Athenex, Inc.
1
Avexa
1
Boston Pharmaceuticals
1
EMD Serono Research & Development Institute, Inc.
1
Hospital do Coracao
1
Total Rows: 17

Clinical Trials at Hospital Nacional Cayetano Heredia


During the past decade, Hospital Nacional Cayetano Heredia conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 13 clinical trials were completed, i.e. on average, 48.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44334444337711110000111111551122Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
2001-02-01
2003-04-01
Completed
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
2001-02-01
2003-09-01
Completed
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
2010-01-01
2013-09-01
Completed
156
Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
2008-02-01
2010-01-01
Terminated
239
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
2009-02-01
2011-03-01
Completed
1,988
Pilot Study: Lactoferrin for Prevention of Neonatal Sepsis
2010-12-01
2011-12-01
Completed
190
Lactoferrin for Prevention of Sepsis in Infants
2012-05-01
2016-10-01
Completed
414
Management of Myocardial Injury After Noncardiac Surgery Trial
2013-01-01
2018-03-01
Completed
1,754

Rows per page:

1–39 of 39

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Nacional Cayetano Heredia" #1 sponsor was "Universidad Peruana Cayetano Heredia" with 13 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Mallinckrodt" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Cayetano Heredia" #1 collaborator was "Johns Hopkins University" with 2 trials as a collaborator, "American Thoracic Society" with 1 trials as a collaborator, "Asociacion Benefica Prisma" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "Barcelona Institute for Global Health" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversidad PeruanaCayetano Heredia: 13Universidad PeruanaCayetano Heredia: 13Hoffmann-La Roche: 6Hoffmann-La Roche: 6Bristol-Myers Squibb: 4Bristol-Myers Squibb: 4Genentech, Inc.: 2Genentech, Inc.: 2Mallinckrodt: 2Mallinckrodt: 2Apellis Pharmaceuticals, Inc.: 1Apellis Pharmaceuticals, Inc.: 1Athenex, Inc.: 1Athenex, Inc.: 1Avexa: 1Avexa: 1Boston Pharmaceuticals: 1Boston Pharmaceuticals: 1EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsJohns Hopkins University: 2Johns Hopkins University: 2American Thoracic Society: 1American Thoracic Society: 1Asociacion Benefica Prisma: 1Asociacion Benefica Prisma: 1Austrian Breast andColorectal CancerGroup: 1Austrian Breast andColorectal CancerGroup: 1Barcelona Institute forGlobal Health: 1Barcelona Institute forGlobal Health: 1Breast International Group: 1Breast International Group: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Chinese University ofHong Kong: 1Chinese University ofHong Kong: 1Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD): 1Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD): 1Fogarty InternationalCenter of the NationalInstitute of Health: 1Fogarty InternationalCenter of the NationalInstitute of Health: 1

Clinical Trials Conditions at Hospital Nacional Cayetano Heredia


According to Clinical.Site data, the most researched conditions in "Hospital Nacional Cayetano Heredia" are "HIV Infections" (3 trials), "Lupus Nephritis" (3 trials), "Covid19" (2 trials), "Neurocysticercosis" (2 trials) and "SARS-CoV-2" (2 trials). Many other conditions were trialed in "Hospital Nacional Cayetano Heredia" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Nacional Cayetano Heredia


Most popular intervention types in "Hospital Nacional Cayetano Heredia" are "Drug" (28 trials), "Behavioral" (4 trials), "Biological" (4 trials), "Other" (4 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Atezolizumab" (3 trials), "Maltodextrin" (3 trials), "Prednisone" (3 trials) and "Atazanavir" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Nacional Cayetano Heredia


The vast majority of trials in "Hospital Nacional Cayetano Heredia" are 36 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Hospital Nacional Cayetano Heredia


Currently, there are NaN active trials in "Hospital Nacional Cayetano Heredia". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Hospital Nacional Cayetano Heredia, undefined suspended trials, and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Nacional Cayetano Heredia, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 22Phase 3: 22Phase 2: 14Phase 2: 14Not Applicable: 5Not Applicable: 5Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 26Completed: 26Terminated: 8Terminated: 8Active, not recruiting: 3Active, not recruiting: 3Enrolling by invitation: 1Enrolling by invitation: 1Recruiting: 1Recruiting: 1